Goodwill and Intangible Asset Disclosure
Adjustments to Financial Statements: Removal of Goodwill
Adjusted Financial Ratios: Removal of Goodwill (Summary)
Adjusted Total Asset Turnover
Adjusted Financial Leverage
Adjusted Return on Equity (ROE)
Adjusted Return on Assets (ROA)

DexCom Inc., balance sheet: goodwill and intangible assets

US$ in thousands

	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Goodwill	25,700)	26,500)	19,300)	18,600)	18,700)
Verily intangible asset	152,400)	—)	—)	—)	—)
Customer relationships	24,100)	22,900)	—)	—)	—)
Acquired technology and intellectual property	14,600)	15,200)	—)	—)	—)
Trademarks and trade name	4,200)	4,400)	—)	—)	—)
Intangibles, other	200)	300)	—)	—)	—)
Intangibles, gross carrying amount	195,500)	42,800)	—)	—)	—)
Accumulated amortization	(22,200)	(11,300)	—)	—)	—)
Intangibles, net carrying amount	173,300)	31,500)	—)	—)	—)
Goodwill and intangibles	199,000)	58,000)	19,300)	18,600)	18,700)

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Download chart

Item	Description	The company
Goodwill	Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.	DexCom Inc. goodwill increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Intangibles, net carrying amount	Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.	DexCom Inc. intangibles, net carrying amount increased from 2020 to 2021 and from 2021 to 2022.
Goodwill and intangibles	Sum of the carrying amounts of all intangible assets, including goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.	DexCom Inc. goodwill and intangibles increased from 2020 to 2021 and from 2021 to 2022.

DexCom Inc., adjustments to financial statements

US$ in thousands

	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Adjustment to Total Assets
Total assets (as reported)	5,391,700)	4,863,600)	4,290,500)	2,395,000)	1,916,000)
Less: Goodwill	25,700)	26,500)	19,300)	18,600)	18,700)
Total assets (adjusted)	5,366,000)	4,837,100)	4,271,200)	2,376,400)	1,897,300)
Adjustment to Stockholders’ Equity
Stockholders’ equity (as reported)	2,131,800)	2,251,500)	1,826,500)	882,600)	663,300)
Less: Goodwill	25,700)	26,500)	19,300)	18,600)	18,700)
Stockholders’ equity (adjusted)	2,106,100)	2,225,000)	1,807,200)	864,000)	644,600)

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

DexCom Inc., Financial Data: Reported vs. Adjusted

Download chart

DexCom Inc., adjusted financial ratios

	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Total Asset Turnover
Reported total asset turnover	0.54	0.50	0.45	0.62	0.54
Adjusted total asset turnover	0.54	0.51	0.45	0.62	0.54
Financial Leverage
Reported financial leverage	2.53	2.16	2.35	2.71	2.89
Adjusted financial leverage	2.55	2.17	2.36	2.75	2.94
Return on Equity (ROE)
Reported ROE	16.01%	6.87%	27.02%	11.45%	-19.16%
Adjusted ROE	16.20%	6.95%	27.31%	11.70%	-19.72%
Return on Assets (ROA)
Reported ROA	6.33%	3.18%	11.50%	4.22%	-6.63%
Adjusted ROA	6.36%	3.20%	11.56%	4.25%	-6.70%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Financial ratio	Description	The company
Adjusted total asset turnover	An activity ratio calculated as total revenue divided by adjusted total assets.	DexCom Inc. adjusted total asset turnover ratio improved from 2020 to 2021 and from 2021 to 2022.
Adjusted financial leverage	A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity. Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.	DexCom Inc. adjusted financial leverage ratio decreased from 2020 to 2021 but then increased from 2021 to 2022 exceeding 2020 level.
Adjusted ROE	A profitability ratio calculated as net income divided by adjusted shareholders’ equity.	DexCom Inc. adjusted ROE deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.
Adjusted ROA	A profitability ratio calculated as net income divided by adjusted total assets.	DexCom Inc. adjusted ROA deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.

DexCom Inc., Financial Ratios: Reported vs. Adjusted

Download chart

	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
As Reported
Selected Financial Data (US$ in thousands)
Revenue	2,909,800)	2,448,500)	1,926,700)	1,476,000)	1,031,600)
Total assets	5,391,700)	4,863,600)	4,290,500)	2,395,000)	1,916,000)
Activity Ratio
Total asset turnover¹	0.54	0.50	0.45	0.62	0.54
Adjusted for Goodwill
Selected Financial Data (US$ in thousands)
Revenue	2,909,800)	2,448,500)	1,926,700)	1,476,000)	1,031,600)
Adjusted total assets	5,366,000)	4,837,100)	4,271,200)	2,376,400)	1,897,300)
Activity Ratio
Adjusted total asset turnover²	0.54	0.51	0.45	0.62	0.54

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

2022 Calculations

¹ Total asset turnover = Revenue ÷ Total assets
= 2,909,800 ÷ 5,391,700 = 0.54

² Adjusted total asset turnover = Revenue ÷ Adjusted total assets
= 2,909,800 ÷ 5,366,000 = 0.54

Download chart

Activity ratio	Description	The company
Adjusted total asset turnover	An activity ratio calculated as total revenue divided by adjusted total assets.	DexCom Inc. adjusted total asset turnover ratio improved from 2020 to 2021 and from 2021 to 2022.

	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
As Reported
Selected Financial Data (US$ in thousands)
Total assets	5,391,700)	4,863,600)	4,290,500)	2,395,000)	1,916,000)
Stockholders’ equity	2,131,800)	2,251,500)	1,826,500)	882,600)	663,300)
Solvency Ratio
Financial leverage¹	2.53	2.16	2.35	2.71	2.89
Adjusted for Goodwill
Selected Financial Data (US$ in thousands)
Adjusted total assets	5,366,000)	4,837,100)	4,271,200)	2,376,400)	1,897,300)
Adjusted stockholders’ equity	2,106,100)	2,225,000)	1,807,200)	864,000)	644,600)
Solvency Ratio
Adjusted financial leverage²	2.55	2.17	2.36	2.75	2.94

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

2022 Calculations

¹ Financial leverage = Total assets ÷ Stockholders’ equity
= 5,391,700 ÷ 2,131,800 = 2.53

² Adjusted financial leverage = Adjusted total assets ÷ Adjusted stockholders’ equity
= 5,366,000 ÷ 2,106,100 = 2.55

Download chart

Solvency ratio	Description	The company
Adjusted financial leverage	A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity. Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.	DexCom Inc. adjusted financial leverage ratio decreased from 2020 to 2021 but then increased from 2021 to 2022 exceeding 2020 level.

	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
As Reported
Selected Financial Data (US$ in thousands)
Net income (loss)	341,200)	154,700)	493,600)	101,100)	(127,100)
Stockholders’ equity	2,131,800)	2,251,500)	1,826,500)	882,600)	663,300)
Profitability Ratio
ROE¹	16.01%	6.87%	27.02%	11.45%	-19.16%
Adjusted for Goodwill
Selected Financial Data (US$ in thousands)
Net income (loss)	341,200)	154,700)	493,600)	101,100)	(127,100)
Adjusted stockholders’ equity	2,106,100)	2,225,000)	1,807,200)	864,000)	644,600)
Profitability Ratio
Adjusted ROE²	16.20%	6.95%	27.31%	11.70%	-19.72%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

2022 Calculations

¹ ROE = 100 × Net income (loss) ÷ Stockholders’ equity
= 100 × 341,200 ÷ 2,131,800 = 16.01%

² Adjusted ROE = 100 × Net income (loss) ÷ Adjusted stockholders’ equity
= 100 × 341,200 ÷ 2,106,100 = 16.20%

Download chart

Profitability ratio	Description	The company
Adjusted ROE	A profitability ratio calculated as net income divided by adjusted shareholders’ equity.	DexCom Inc. adjusted ROE deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.

	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
As Reported
Selected Financial Data (US$ in thousands)
Net income (loss)	341,200)	154,700)	493,600)	101,100)	(127,100)
Total assets	5,391,700)	4,863,600)	4,290,500)	2,395,000)	1,916,000)
Profitability Ratio
ROA¹	6.33%	3.18%	11.50%	4.22%	-6.63%
Adjusted for Goodwill
Selected Financial Data (US$ in thousands)
Net income (loss)	341,200)	154,700)	493,600)	101,100)	(127,100)
Adjusted total assets	5,366,000)	4,837,100)	4,271,200)	2,376,400)	1,897,300)
Profitability Ratio
Adjusted ROA²	6.36%	3.20%	11.56%	4.25%	-6.70%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

2022 Calculations

¹ ROA = 100 × Net income (loss) ÷ Total assets
= 100 × 341,200 ÷ 5,391,700 = 6.33%

² Adjusted ROA = 100 × Net income (loss) ÷ Adjusted total assets
= 100 × 341,200 ÷ 5,366,000 = 6.36%

Download chart

Profitability ratio	Description	The company
Adjusted ROA	A profitability ratio calculated as net income divided by adjusted total assets.	DexCom Inc. adjusted ROA deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.

DexCom Inc. (NASDAQ:DXCM)

Analysis of Goodwill and Intangible Assets

Goodwill and Intangible Asset Disclosure

Adjustments to Financial Statements: Removal of Goodwill

DexCom Inc., Financial Data: Reported vs. Adjusted

Adjusted Financial Ratios: Removal of Goodwill (Summary)

DexCom Inc., Financial Ratios: Reported vs. Adjusted

Adjusted Total Asset Turnover

Adjusted Financial Leverage

Adjusted Return on Equity (ROE)

Adjusted Return on Assets (ROA)